找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Capsaicin as a Therapeutic Molecule; Omar M. E. Abdel-Salam Book 2014 Springer Basel 2014 analgesic substance.capsaicin.resiniferatoxin.va

[復(fù)制鏈接]
11#
發(fā)表于 2025-3-23 11:05:45 | 只看該作者
Pharmacology of the Capsaicin Receptor, Transient Receptor Potential Vanilloid Type-1 Ion Channel,1. However, it is believed that better understanding of the pharmacological properties of TRPV1 and specific targeting of tissues may eventually lead to the development of clinically useful agents. In order to assist better understanding of TRPV1 pharmacology, here we are giving a comprehensive acco
12#
發(fā)表于 2025-3-23 13:55:28 | 只看該作者
13#
發(fā)表于 2025-3-23 19:55:48 | 只看該作者
14#
發(fā)表于 2025-3-23 23:48:34 | 只看該作者
15#
發(fā)表于 2025-3-24 06:00:03 | 只看該作者
16#
發(fā)表于 2025-3-24 06:49:11 | 只看該作者
Capsaicin Receptor as Target of Calcitonin Gene-Related Peptide in the Gut, the activation of TRPV-1 has been shown to protect from gastric damage induced by several stimuli and to be involved in gastritis. In both dyspepsia and irritable bowel syndrome the repeated stimulation of TRPV-1 induced an improvement in epigastric pain of these patients. The TRPV-1/CGRP pathway m
17#
發(fā)表于 2025-3-24 14:25:41 | 只看該作者
Capsaicin for Osteoarthritis Pain,atment. There was no heterogeneity between studies, indicating no between-study differences, including effect of OA site or treatment concentration. Two studies reported treatment beyond 4?weeks, with divergent results. One study reported an effect size of ?9?mm after 12?weeks, and maximal between-g
18#
發(fā)表于 2025-3-24 15:06:48 | 只看該作者
Use of Vanilloids in Urologic Disorders,ptor agonist to placebo and those in English were reviewed. We conclude that capsaicin and RTX do appear to provide some acceptable treatment results in patients with neurogenic bladder, though larger studies are needed to confirm this. Although efficacy has been shown in some studies, currently the
19#
發(fā)表于 2025-3-24 20:11:45 | 只看該作者
20#
發(fā)表于 2025-3-24 23:31:44 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 08:06
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
武邑县| 陆河县| 晋宁县| 昌江| 社会| 临夏市| 昌都县| 雷山县| 凤台县| 二连浩特市| 久治县| 南丰县| 古交市| 公安县| 敦煌市| 开封市| 桂林市| 宁城县| 东源县| 东乡族自治县| 于都县| 措美县| 太仆寺旗| 离岛区| 灌南县| 宣威市| 白朗县| 合作市| 喀喇| 晋城| 绍兴县| 洪江市| 慈利县| 云南省| 蓝山县| 云梦县| 景德镇市| 安宁市| 五华县| 鹰潭市| 即墨市|